Evidence map›Paper›PMID 27896065›Full record

ArticleNeuroImage. Clinical2017

Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.

Courtney A Bishop, Rexford D Newbould, Jean Sz Lee, Lesley Honeyfield, Rebecca Quest, Alessandro Colasanti, Rehiana Ali, Miriam Mattoscio, Antonio Cortese, Richard Nicholas and 3 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Courtney A BishopImanova Centre for Imaging Sciences, London, UK.
Rexford D NewbouldImanova Centre for Imaging Sciences, London, UK.
Jean Sz LeeDivision of Brain Sciences, Imperial College London, UK; Department of Imaging, Imperial College Healthcare NHS Trust, London, UK.
Lesley HoneyfieldDepartment of Imaging, Imperial College Healthcare NHS Trust, London, UK.
Rebecca QuestDepartment of Imaging, Imperial College Healthcare NHS Trust, London, UK.
Alessandro ColasantiDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Rehiana AliDivision of Brain Sciences, Imperial College London, UK.
Miriam MattoscioDivision of Brain Sciences, Imperial College London, UK.
Antonio CorteseDivision of Brain Sciences, Imperial College London, UK; Department of Neurology and Psychiatry, Sapienza University of Rome, Italy.
Richard NicholasDivision of Brain Sciences, Imperial College London, UK.
Paul M MatthewsDivision of Brain Sciences, Imperial College London, UK.
Paolo A MuraroDivision of Brain Sciences, Imperial College London, UK.
Adam D WaldmanDivision of Brain Sciences, Imperial College London, UK; Centre for Clinical Brain Sciences, University of Edinburgh, UK.
Imperial College London · GBImperial College Healthcare NHS Trust · GBLivaNova (United Kingdom) · GBKing's College London · GB

Funding

Medical Research Council G0800679Medical Research Council MC_PC_17114
6 · The paper itself

Abstract

Age of onset in multiple sclerosis (MS) exerts an influence on the course of disease. This study examined whether global and regional brain volumes differed between "younger" and "older" onset MS subjects who were matched for short disease duration, mean 1.9 years and burden as measured by the MS Severity Score and relapses. 21 younger-onset MS subjects (age 30.4 ± 3.2 years) were compared with 17 older-onset (age 48.7 ± 3.3 years) as well as age-matched controls (

Indexed as

AdultAge FactorsAge of OnsetAgingAmygdalaAtrophyCorpus StriatumGray MatterHippocampusHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisThalamusAtrophyGrey matterImage analysisMagnetic resonance imagingMultiple sclerosis

Identifiers

PMID27896065
PMCPMC5121150
OpenAlexW2556196859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.